Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02826265
Recruitment Status : Recruiting
First Posted : July 7, 2016
Last Update Posted : April 16, 2019
Sponsor:
Information provided by (Responsible Party):
Dr. Frederik Trinkmann, Universitätsmedizin Mannheim

Brief Summary:
Current diagnostic tools used in pulmonary disease often do not meet the challenges set by the respective pathophysiology. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of patients with various pulmonary diseases.

Condition or disease Intervention/treatment
Chronic Obstructive Pulmonary Disease Bronchial Asthma Interstitial Lung Disease Device: multiple breath washout test (MBW) Device: impulse oscillometry (IOS) Device: body plethysmography (BP) Device: quantitative computed tomography (qCT)

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease
Study Start Date : January 2016
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
pulmonary disease
patients with known or suspected pulmonary disease
Device: multiple breath washout test (MBW)
Device: impulse oscillometry (IOS)
Device: body plethysmography (BP)
Device: quantitative computed tomography (qCT)
ultra-low-dose qCT




Primary Outcome Measures :
  1. correlation of lung clearance index (LCI) as determined by multiple breath washout with emphysema quantification as determined by qCT [ Time Frame: 2 weeks ]
  2. correlation of airway resistance and reactance (R5, X5, R-D5-20) as determined by impulse oscillometry with emphysema quantification as determined by qCT [ Time Frame: 2 weeks ]
  3. correlation of residual volume and airway resistance as determined by body plethysmography with and emphysema quantification as determined by qCT [ Time Frame: 2 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with indication for routine lung function testing and computed tomography
Criteria

Inclusion Criteria:

  • known or suspected pulmonary lung disease
  • indication for computed tomography

Exclusion Criteria:

  • pregnancy
  • inability to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02826265


Contacts
Layout table for location contacts
Contact: Frederik Trinkmann, Dr. +496213833879 frederik.trinkmann@umm.de

Locations
Layout table for location information
Germany
Universitätsmedizin Mannheim Recruiting
Mannheim, Germany, 68167
Contact: Frederik Trinkmann, Dr.    +49    frederik.trinkmann@umm.de   
Principal Investigator: Frederik Trinkmann, Dr.         
Principal Investigator: Joachim Saur, Prof. Dr.         
Principal Investigator: Thomas Henzler, Prof. Dr.         
Sponsors and Collaborators
Universitätsmedizin Mannheim

Layout table for additonal information
Responsible Party: Dr. Frederik Trinkmann, Principal Investigator, Universitätsmedizin Mannheim
ClinicalTrials.gov Identifier: NCT02826265     History of Changes
Other Study ID Numbers: MBW-qCT
First Posted: July 7, 2016    Key Record Dates
Last Update Posted: April 16, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Interstitial
Asthma
Respiratory Tract Diseases
Bronchial Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases